GlaxoSmithKline Inc. v. Pharmascience Inc.
Peter Wilcox successfully acted for GlaxoSmithKline in a proceeding in which attacks on the validity of the patent covering GSK’s diabetes medication AVANDIA® were dismissed.
Peter Wilcox successfully acted for GlaxoSmithKline in a proceeding in which attacks on the validity of the patent covering GSK’s diabetes medication AVANDIA® were dismissed.
